Facetten
Zugriff
Einrichtung
Medientyp
- Text 8
Karte
Erscheinungsjahr
Autor/in
- Pfisterer, Jacobus
- Mahner, Sven 5
- Harter, Philipp 3
- Heitz, Florian 3
- Sehouli, Jalid 3
- alle zeigen
Sprache
8 Einträge gefunden
-
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer:AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial
- Pfisterer, Jacobus
- Joly, Florence
- Kristensen, Gunnar
- Rau, Joern
- Mahner, Sven
- Pautier, Patricia
- El-Balat, Ahmed
-
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
- Wimberger, Pauline
- Gerber, Mara Julia
- Pfisterer, Jacobus
- Erdmann, Kati
- Füssel, Susanne
- Link, Theresa
- du Bois, Andreas
-
-
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
- Emons, Günter
- Kurzeder, Christian
- Schmalfeldt, Barbara
- Neuser, Petra
- de Gregorio, Nikolaus
- Pfisterer, Jacobus
- Park-Simon, Tjoung-Won
-
-
A phase 3 trial of bevacizumab in ovarian cancer
- Perren, Timothy J
- Swart, Ann Marie
- Pfisterer, Jacobus
- Ledermann, Jonathan A
- Pujade-Lauraine, Eric
- Kristensen, Gunnar
- Carey, Mark S
-
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.
2010 - Forschungsinformationssystem des UKE -
Prognostic factors for complete debulking in first- and second-line ovarian cancer.
- Harter, Philipp
- Hilpert, Felix
- Mahner, Sven
- Kommoss, Stefan
- Heitz, Florian
- Pfisterer, Jacobus
- Andreas, Du Bois